Anthrogenesis Corporation
66Patents
58Active
66Granted
53Portfolio score
Filing activity: Dec 5, 2001 → Nov 18, 2014 · 28 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7909806B2 | Cord blood and placenta collection kit | Performing Operations; Transporting | 178 | Active |
| US7311905B2 | Embryonic-like stem cells derived from post-partum mammalian placenta, and uses and methods of treatment using said cells | Chemistry; Metallurgy | 178 | Expired |
| US7311904B2 | Tissue matrices comprising placental stem cells, and methods of making the same | Chemistry; Metallurgy | 160 | Expired |
| US7045148B2 | Method of collecting placental stem cells | Chemistry; Metallurgy | 150 | Expired |
| US7468276B2 | Placental stem cells | Chemistry; Metallurgy | 109 | Expired |
| US8071135B2 | Placental tissue compositions | Human Necessities | 104 | Active |
| US8105634B2 | Umbilical cord biomaterial for medical use | Human Necessities | 96 | Active |
| US7498171B2 | Modulation of stem and progenitor cell differentiation, assays, and uses thereof | Chemistry; Metallurgy | 93 | Expired |
| US7255879B2 | Post-partum mammalian placenta, its use and placental stem cells therefrom | Chemistry; Metallurgy | 91 | Expired |
| US7928280B2 | Treatment of leg ulcers using placenta derived collagen biofabric | Emerging Cross-Sectional Technologies | 77 | Active |
| US7682803B2 | Immunomodulation using placental stem cells | Chemistry; Metallurgy | 77 | Active |
| US7914779B2 | Tissue matrices comprising placental stem cells, and methods of making the same | Chemistry; Metallurgy | 70 | Active |
| US7638141B2 | Isolated placental perfusate and placental cells isolated therefrom | Chemistry; Metallurgy | 62 | Expired |
| US7976836B2 | Treatment of stroke using placental stem cells | Chemistry; Metallurgy | 60 | Active |
| US7993918B2 | Tumor suppression using placental stem cells | Chemistry; Metallurgy | 54 | Active |
| US7700090B2 | Co-culture of placental stem cells and stem cells from a second source | Chemistry; Metallurgy | 51 | Active |
| US8057788B2 | Placental stem cell populations | Chemistry; Metallurgy | 43 | Active |
| US8071376B2 | Production of oligodendrocytes from placenta-derived stem cells | Chemistry; Metallurgy | 36 | Active |
| US8057789B2 | Placental stem cells derived from post-partum mammalian placenta, and uses and methods of treatment using said cells | Chemistry; Metallurgy | 34 | Active |
| US8202703B2 | Placental stem cell populations | Chemistry; Metallurgy | 25 | Active |
| US8367409B2 | Amnion derived adherent cells | Human Necessities | 25 | Active |
| US8263065B2 | Tumor suppression using human placental perfusate and human placenta-derived intermediate natural killer cells | Human Necessities | 23 | Active |
| US8562972B2 | Methods and compositions for treatment of bone defects with placental cell populations | Chemistry; Metallurgy | 18 | Active |
| US8926964B2 | Methods of generating natural killer cells | Emerging Cross-Sectional Technologies | 17 | Active |
| US8293223B2 | Treatment of organ injuries and burns using placental stem cells | Chemistry; Metallurgy | 17 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.